Almeda Ventures

Experienced HealthTech investor who was previously a partner at Accelmed leading VC and PE investments in Israel and the US. Trained as a biotechnology engineer at the Technion and holds an MBA from Tel Aviv University.

A physician and senior executive with over 25 years of experience across venture capital, pharma, and biotech, previously a partner at Accelmed since 2012 where she led Eximo from pre-clinical development through acquisition. Holds an MD from Ben-Gurion University and an MBA from Tel Aviv University.

A prominent figure in the Israeli capital market and Chairman of Discount Capital Underwriting; founded Clal Finance Underwriting with over 25 years of underwriting experience. Holds a BA in Economics and an MBA from Hebrew University of Jerusalem.

A senior executive with over 20 years in healthcare innovation and medtech startups, formerly CEO of AV Medical Technologies (acquired by Medtronic) and a partner at Access Medical Ventures. Holds a BSc in Chemical Engineering and an ME in Industrial Design from the Technion.

An executive clinician with over 30 years of experience in health strategy, coverage, and reimbursement, working extensively with CMS and the AMA on coding and payment systems. Board certified in internal medicine and gastroenterology.

Brings over two decades of experience in venture capital, private equity, and cross-border investments focused on healthtech, medtech, and digital health. Previously a partner at Olive Tree Ventures and held senior roles at Clal Finance and Sage Capital Global. Holds an LL.B from the University of Essex and an LL.M from Bar-Ilan University.

A licensed patent attorney since 2004 and adjunct faculty at the Technion, specializing in IP portfolio management, patent prosecution, and pre-investment due diligence. Holds a PhD in Physical and Analytical Chemistry from the Technion.

A cardiologist with over 25 years of experience in patient care and clinical research, serving as Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation and Professor of Medicine at UCSD. Author of over 130 peer-reviewed publications.

A regulatory expert specializing in bringing medical devices to global markets, formerly Corporate SVP for Global Regulatory at Medtronic and VP Regulatory Science at C.R. Bard. Previously held management positions at the US FDA from 1987-2000.

A certified public accountant with experience in hedge funds and publicly quoted companies; serves as director of finance at Total Finance. Holds an Executive MBA from Hebrew University, Jerusalem.